- Home
- PYPD vs STRR Comparison
PYPD vs STRR Comparison
Compare PYPD & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- STRR
- Stock Information
- Founded
- PYPD 2008
- STRR 1985
- Country
- PYPD Israel
- STRR United States
- Employees
- PYPD N/A
- STRR N/A
- Industry
- PYPD Medical/Dental Instruments
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PYPD Health Care
- STRR Health Care
- Exchange
- PYPD Nasdaq
- STRR Nasdaq
- Market Cap
- PYPD 16.3M
- STRR 13.3M
- IPO Year
- PYPD 2020
- STRR N/A
- Fundamental
- Price
- PYPD $3.51
- STRR $4.02
- Analyst Decision
- PYPD Buy
- STRR
- Analyst Count
- PYPD 2
- STRR 0
- Target Price
- PYPD $12.00
- STRR N/A
- AVG Volume (30 Days)
- PYPD 5.2K
- STRR 9.3K
- Earning Date
- PYPD 11-06-2024
- STRR 11-06-2024
- Dividend Yield
- PYPD N/A
- STRR N/A
- EPS Growth
- PYPD N/A
- STRR N/A
- EPS
- PYPD N/A
- STRR N/A
- Revenue
- PYPD N/A
- STRR $47,147,000.00
- Revenue This Year
- PYPD N/A
- STRR $19.97
- Revenue Next Year
- PYPD N/A
- STRR $41.50
- P/E Ratio
- PYPD N/A
- STRR N/A
- Revenue Growth
- PYPD N/A
- STRR N/A
- 52 Week Low
- PYPD $2.95
- STRR $3.43
- 52 Week High
- PYPD $9.20
- STRR $6.55
- Technical
- Relative Strength Index (RSI)
- PYPD 50.62
- STRR 45.04
- Support Level
- PYPD $3.31
- STRR $3.89
- Resistance Level
- PYPD $3.62
- STRR $4.29
- Average True Range (ATR)
- PYPD 0.17
- STRR 0.23
- MACD
- PYPD 0.01
- STRR -0.01
- Stochastic Oscillator
- PYPD 51.25
- STRR 19.70
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.